ArticleCancers2026
Real-World Application of PD-1 Inhibitors in High-Grade Glioma: A Case Series.
Yin Ren, Xiaopeng Guo, Hao Xing, Xiaoman Kang, Tingyu Liang, Yixin Shi, Bohan Yao, Wenbin Ma, Yu Wang
Abstract read
In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Yin RenDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Xiaopeng GuoDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.ORCID 0000-0002-4183-5560 Hao XingDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Xiaoman KangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Tingyu LiangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Yixin ShiDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Bohan YaoDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Wenbin MaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Yu WangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.ORCID 0000-0002-7175-4649 Funding
Beijing Municipal Natural Science Foundation F252060CAMS Innovation Fund for Medical Sciences (CIFMS) 2024-I2M-C&T-B-021Innovative Drug Research and Development - National Science and Technology Major Project 2026ZD1804600National High Level Hospital Clinical Research Funding 2025-PUMCH-A-156National High Level Hospital Clinical Research Funding 2025-PUMCH-A-158Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2024-JKCS-23Peking Union Medical College Hospital Talent Cultivation Program (Category C) UBJ10254Peking Union Medical College Hospital Talent Cultivation Program (Category D) UHB12428
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
combination therapyhigh-grade gliomaneoadjuvant anti-PD-1 therapyPD-1 blockadeVEGFR-targeted therapy
Identifiers
PMID42882817
PMCPMC13664033
What OpenQuestion holds
Textmetadata
Read underepoch 390